← back to search

David R. Rubinow

University of North Carolina at Chapel Hill · US
Area of research
Public Health, Environmental and Occupational Health · Behavioral Neuroscience
Research interest
Research interests include Stress Responses and Cortisol, Menstrual Health and Disorders, Menopause: Health Impacts and Treatments, and Neuroendocrine regulation and behavior.
h-index
85
citations
25,230
works
413
NIH funding
primary concept
email

Recent publications

Suppression of Endogenous Alpha Power Predicts Clinical Response to 10 Hz tACS in Major Depressive Disorder: A Double-Blind Randomized Controlled Trial
2026cited by 2position: contributordoi
Sustained benefits of closed-loop transcranial alternating current stimulation (CL-tACS) on depression: a 12-week open-label clinical trial.
2026cited by 0position: contributordoi
Esr1-Dependent Signaling and Transcriptional Maturation in the Medial Preoptic Area of the Hypothalamus Shapes the Development of Mating Behavior during Adolescence
eLife 2025cited by 2position: middledoi
Differential sensitivity: not more or less.
2025cited by 1position: contributordoi
David R. Rubinow: Triggers and susceptibility–reproductive steroids and the regulation of affective state
Brain Medicine 2025cited by 0position: contributordoi
Temporal dynamics of neurobehavioral hormone sensitivity in a scaled-down experimental model of early pregnancy and parturition.
2024cited by 15position: contributordoi
Epigenetic aging and PTSD outcomes in the immediate aftermath of trauma
Psychological Medicine 2023cited by 26position: middledoi
Temporal dynamics of neurobehavioral hormone sensitivity in a scaled-down experimental model of early pregnancy and parturition
Neuropsychopharmacology 2023cited by 19position: middledoi
Cyclical exacerbation of suicidal ideation in female outpatients: Prospective evidence from daily ratings in a transdiagnostic sample.
Journal of Psychopathology and Clinical Science 2023cited by 16position: middledoi
GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder.
2023cited by 11position: contributordoi
Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program
Journal of Affective Disorders 2022cited by 69position: middledoi
Effects of acute estradiol and progesterone on perimenstrual exacerbation of suicidal ideation and related symptoms: a crossover randomized controlled trial
Translational Psychiatry 2022cited by 40position: middledoi
Reduction in left frontal alpha oscillations by transcranial alternating current stimulation in major depressive disorder is context-dependent in a randomized-clinical trial
2021cited by 3position: contributordoi
HPA axis regulation and epigenetic programming of immune-related genes in chronically stressed and non-stressed mid-life women
Brain Behavior and Immunity 2020cited by 41position: middledoi
Test-statistic inflation in methylome-wide association studies
Epigenetics 2020cited by 36position: middledoi
Effects of perimenopausal transdermal estradiol on self-reported sleep, independent of its effect on vasomotor symptom bother and depressive symptoms
Menopause The Journal of The North American Menopause Society 2019cited by 31position: middledoi
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
The Lancet 2018cited by 777position: middledoi
Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium
The Lancet Psychiatry 2017cited by 306position: middledoi
Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of postpartum women
Psychological Medicine 2017cited by 162position: middledoi
The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale
Psychological Medicine 2016cited by 97position: middledoi
Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder
Archives of Women s Mental Health 2016cited by 95position: middledoi
ISPMD consensus on the management of premenstrual disorders
Archives of Women s Mental Health 2013cited by 208position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 7 papers (2021–2026)Samantha Meltzer‐Brody · University of North Carolina at Chapel Hill4 papers (2017–2022)C. Neill Epperson · Colorado School of Public Health4 papers (2013–2022)Jerry Guintivano · University of North Carolina at Chapel Hill3 papers (2017–2020) · 3 papers (2019–2023)Stephen Kanes · University of Massachusetts Chan Medical School2 papers (2018–2022)Candace Brown · Eunice Kennedy Shriver National Institute of Child Health and Human Development2 papers (2013–2016)Andrea J. Rapkin · University of California, Los Angeles2 papers (2013–2016)Nicholas Panay · Imperial College Healthcare NHS Trust2 papers (2013–2016) · 2 papers (2013–2016)Uriel Halbreich · University of Birmingham2 papers (2013–2016)Peter J. Schmidt · Tufts University2 papers (2013–2016) · 2 papers (2013–2016)Katja M. Schmalenberger · University of Illinois Chicago2 papers (2022–2023)Robert Riesenberg · Peninsula Research2 papers (2018–2022)Meir Steiner · Hospital for Sick Children2 papers (2013–2016) · 2 papers (2022–2023) · 2 papers (2022–2023)Kristina M. Deligiannidis · University of Massachusetts Chan Medical School2 papers (2018–2022) · 2 papers (2020–2023)